• Facebook
  • Twitter
  • Instagram
  • Youtube
  • LinkedIn
  • Take Action
  • Partner With Us
  • DONATE
National Consumers League
  • About NCL
    • About Us
    • Our Programs
    • Leadership
    • Trumpeter Awards
    • Legal Work
    • Careers
  • Our Work
    • Consumer Education
    • Consumer Protection
    • Food & Nutrition
    • Fraud Prevention
    • Health
    • Workers Rights
  • Where We Stand
    • Consumer Education
    • Consumer Protection
    • Fraud Prevention
    • Food & Nutrition
    • Health
    • Workers Rights
    • Other NCL Positions
  • Blog
  • Publications
    • Annual Report
    • Bulletin
    • Sign Up for Our Newsletters
  • Media
    • Press Releases
    • Podcast
    • NCL in the News
    • Keeping up with Sally & Staff
    • Media Toolkit
  • Contact
  • Search
  • Menu Menu
  • DONATE
  • About NCL
    • About Us
    • Our Programs
    • Leadership
    • Trumpeter Awards
    • Legal Work
    • Careers
  • Our Work
    • Fraud Prevention
    • Health
    • Food & Nutrition
    • Consumer Education
    • Workers Rights
    • Consumer Protection
  • Where We Stand
    • Fraud Prevention
    • Health
    • Food & Nutrition
    • Consumer Education
    • Workers Rights
    • Consumer Protection
  • Blog
  • Publications
    • Annual Report
    • Bulletin
    • Sign Up for Our Newsletters
  • Media
    • Podcast
    • NCL in the News
    • Press Releases
    • Keeping up with Sally & Staff
    • Media Toolkit
  • Contact
  • Take Action
  • Partner With Us

Privacy Policy

As a consumer organization that advocates for strong privacy rights, the National Consumers League (NCL) respects your privacy. NCL only asks for information that is necessary to conduct its activities and does not sell or rent personal information about individuals. NCL does not use “cookies” on any of its Web sites. NCL operates several programs. In some cases personal information about individuals may be shared among programs or with outside organizations. Each NCL program varies in terms of what information is collected and how it is used. Click on each for more details.

If you have any questions or problems concerning NCL’s privacy practices, contact info@nclnet.org or (202) 835-3323.
Alliance Against Fraud
Child Labor Coalition
LifeSmarts
National Consumers League
NCL’s Fraud Center

Alliance Against Fraud

The Alliance Against Fraud (AAF) is a coalition whose mission is to educate the public about telemarketing and Internet fraud. The mailing address is:

Alliance Against Fraud
c/o National Consumers League
1701 K Street NW, Suite 1200
Washington, DC 20006

What information is collected?

  • The AAF collects the names, affiliations, addresses, phone and fax numbers, email and Web site addresses of its members.
  • Records of members’ payments are also retained.
  • Some individuals send letters, faxes or emails to the AAF that may contain personally identifiable information.
  • When people visit www.fraud.org/aaft/, NCL can obtain information from its Internet Service Provider about what countries they came from, what Web sites they visited immediately before, the most popular AAF Web pages visited, and the total number of visitors.
  • Web visitors’ names, email addresses and other personally identifiable information are not collected unless they fill out membership forms, or communicate with the AAF via email.

How is personally identifying information used?

  • The AAF Membership Directory with all contact information is provided to members only.
  • AAF members may be contacted about other activities of the NCL.
  • No personal information about members or other people who contact the AAF, online or offline, is shared with others, except that personal information from consumers who contact the AAF about telemarketing or Internet-related problems may be referred to the appropriate government agencies, trade associations, businesses, advocacy organizations, or other organizations for assistance.
  • Payment information is shared with others only to the extent necessary for processing.

Who do I contact if I have questions or concerns about this privacy policy?

If you have any questions or problems concerning NCL’s privacy practices, contact info@nclnet.org or (202) 835-3323.

Child Labor Coalition

The Child Labor Coalition (CLC), administered by NCL, is a national network for the exchange of information about child labor. The mailing address is:

CLC
c/o National Consumers League
1701 K Street NW, Suite 1200
Washington, DC 20006

What information is collected?

  • The CLC collects the names, affiliations, addresses, phone and fax numbers, email and Web site addresses of its members.
  • The CLC maintains a database of child labor contacts and related organizations (i.e., names, titles, addresses, phone, fax, and email).
  • When the CLC conducts surveys of young workers, their age, gender, and city/state of residence are collected but not their names, email addresses, or other identifying information.
  • People may submit poems or statements about child labor to be posted on our Web site via a form on the CLC Web site. In that case, their names, email addresses, age (if under 18), and school (if applicable) are collected.
  • Some consumers send letters or emails to the CLC that may contain personally identifiable information.
  • Records of payments with personal identifying information (i.e., names, affiliations, addresses, and phone numbers) may also be obtained when individuals order educational materials and make donations to the CLC.
  • CLC also collects names, affiliations, and contact information of reporters for its media list.
  • When people attend CLC conferences or forums, their names, affiliations, addresses, phone and fax numbers, and email addresses are collected.
  • When people visit www.stopchildlabor.org, NCL can obtain information from its Internet Service Provider about what countries they came from, what Web sites they visited immediately before, the most popular CLC Web pages visited, and the total number of visitors.
  • Web visitors’ names, email addresses and other personally identifiable information are not collected unless they have provide them for purposes of membership, list serve subscription, or posting child labor poems or statements on the CLC Web site.
  • When individuals contact the CLC for information, online or offline, their names and physical or email addresses are collected temporarily in order to respond to them.

How is personally identifying information used?

  • The CLC posts members’ organizational affiliations on its Web site, but not their individual names or other identifying information.
  • The CLC Membership Directory with all contact information is provided to members and may occasionally be shared with other non-governmental organizations and/or government agencies for the purpose of disseminating information on child labor-related issues or events.
  • The email addresses of listserv subscribers are not shared with others.
  • CLC conference packets include names and contact information for participants. These lists are treated as public information and are available to anyone who requests them.
  • When people’s poems or statements are posted on the CLC Web site, their names, school affiliations (if applicable), and ages (if under 18) are included.
  • No information about individuals who contact the CLC, online or offline, is shared with others, except that information from consumers who contact the CLC with specific questions or complaints related to child labor laws may be referred to the appropriate state or federal agencies for assistance.
  • NCL obtains explicit permission from individuals who have contacted CLC, online or offline, about child labor situations or accidents before providing their information to the media.
  • Payment information is shared with others only to the extent necessary for processing.
  • The CLC’s media lists are sometimes shared with CLC members and other organizations that want to distribute child labor press releases and alerts.
  • People who are included on the CLC database, listserv, and conference lists, as well as media contacts, may be contacted about other CLC activities or events or activities hosted by CLC member organizations.

Who do I contact if I have questions or concerns about this privacy policy?

If you have any questions or problems concerning NCL’s privacy practices, contact info@nclnet.org org or (202) 835-3323.

LifeSmarts

LifeSmarts is a program to develop the consumer and marketplace skills of teenagers. The mailing address is:

LifeSmarts
c/o National Consumers League
1701 K Street NW, Suite 1200
Washington, DC 20006

What information is collected?

  • LifeSmarts collects the names, addresses, email addresses, ages, grades, and team affiliations of students who participate in its consumer knowledge program.
  • The names, addresses, email addresses, phone and fax numbers, and affiliations of LifeSmarts team coaches and state coordinators are also collected.
  • Quotes and pictures of LifeSmarts participants may be obtained with their permission.
  • Names, addresses, and phone numbers of people who purchase LifeSmarts educational materials are collected in order to fulfill those orders.
  • Records of payments to LifeSmarts are also retained.
  • When people visit www.lifesmarts.org, NCL can obtain information from its Internet Service Provider about what countries they came from, what Web sites they visited immediately before, the most popular LifeSmarts Web pages visited, the total number of visitors. NCL can also gather composite information about the number of hits each question in the database received, and how many times the question was answered correctly or incorrectly. This information is not tied in any way to other information such as people’s names, schools, or individual player’s scores.
  • Web visitors’ names, email addresses, and other personally identifiable information are not collected unless they register on the site to become part of an online LifeSmarts team. If a person uses the site to take practice quizzes, no personally identifying information is collected.


How is personally identifying information used?

  • LifeSmarts uses information about students, coaches and state coordinators to coordinate and monitor the program.
  • State coordinators are given contact information for LifeSmarts team coaches within their states and for coordinators in other states. State coordinators also receive composite team scores and individual player scores for all teams registered for their states. They do not receive personally identifying player information.
  • Coaches receive scores for students on their teams. Throughout the program year, coaches also receive periodic updates about their teams and information pertaining to LifeSmarts. (Note: They do not receive contact information – we assume they already know how to find their own students.)
  • Personally identifying information is not shared with others, except that the names of all participants in the national LifeSmarts competition are distributed at that event.
  • Quotes and pictures are used with the consent of the individuals.
  • LifeSmarts coaches and state coordinators may be contacted about other NCL activities.
  • Students who participate in the LifeSmarts national competition receive a complimentary one-year membership to NCL.
  • Individuals outside of the program who purchase LifeSmarts educational materials are sent information about NCL only if they have explicitly agreed to receive it.
  • Payment information is shared with others only to the extent necessary for processing.


Who do I contact if I have questions or concerns about this privacy policy?

If you have any questions or problems concerning NCL’s privacy practices, contact info@nclnet.org or (202) 835-3323.

National Consumers League

The National Consumers League (NCL) is a private, nonprofit advocacy organization whose mission is to identify, protect, represent, and advance the economic and social interests of consumers and workers. The mailing address is:

NCL
1701 K Street NW, Suite 1200
Washington, DC 20006

What information is collected?

  • NCL collects personal information that members and donors may provide such as names, addresses, affiliations, phone and fax numbers, and email addresses.
  • NCL also collects names, affiliations, and contact information of reporters for its media lists.
  • When people attend NCL conferences or forums, their names, affiliations, addresses, phone and fax numbers, and email addresses are collected.
  • Names and affiliations are collected to make nametags for people who attend events including the annual Trumpeter Award dinner.
  • Names, affiliations, addresses, and phone numbers are collected for orders of NCL educational materials.
  • Records of all payments and donations are also retained.
  • Some individuals send letters, faxes or emails to NCL that may contain personally identifiable information.
  • When people visit www.nclnet.org, NCL can obtain information from its Internet Service Provider about what countries they came from, what Web sites they visited immediately before, the most popular NCL Web pages visited, and the total number of visitors.
  • Visitors’ names, email addresses and other personally identifiable information are not collected unless they make donations, fill out membership forms, order educational materials, or communicate with NCL via email.

How is personally identifying information used?

  • NCL does not produce a membership directory or share information about members with others outside of the organization.
  • NCL packets for conferences and forums include names and contact information for participants. These lists treated as public information and are available to anyone who requests them.
  • Information about individuals who contact NCL, online or offline, about consumer problems may be referred to the appropriate government agencies, trade associations, businesses, advocacy organizations, or other organizations for assistance.
  • NCL will obtain explicit permission from individuals who have contacted it, online or offline, before providing their information to the media.
  • NCL’s media lists are sometimes shared with other organizations in connection with joint education projects.
  • Members, donors, media, and people who participate in NCL conferences, forums and events may receive information about other NCL activities.
  • People who purchase educational materials may be sent information about other NCL activities.
  • Payment information is shared with others only to the extent needed for processing.

Who do I contact if I have questions or concerns about this privacy policy?

If you have any questions or problems concerning NCL’s privacy practices, contact info@nclnet.org or (202) 835-3323.

National Consumers League’s Fraud Center

The National Consumers League’s Fraud Center provides advice about telemarketing and online offers and transmits information reported by individuals about suspected telemarketing and Internet fraud to law enforcement agencies. The mailing address is:

NCL’s Fraud Center
c/o National Consumers League
1701 K Street NW, Suite 1200
Washington, DC 20006

What information is collected?

  • When individuals contact the Fraud Center for advice, online or offline, their names and physical or email addresses are collected temporarily in order to respond to them.
  • Individuals who report suspected telemarketing or Internet fraud are asked for their names, addresses, phone numbers at home and work, email addresses, years of birth, method of payment (but not account numbers) and the names and contact information of the sellers involved.
  • The Fraud Center collects the names, affiliations, phone and fax numbers, and email addresses of law enforcement investigators who have arranged to receive fraud reports.
  • Some individuals send letters or faxes to the Fraud Center that contain personally identifiable information.
  • When people visit www.fraud.org, NCL can obtain information from its Internet Service Provider about what countries they came from, what Web sites they visited immediately before, the most popular Web pages visited, and the total number of visitors.
  • Web visitors’ names, email addresses and other personally identifiable information are not collected unless they make a donation, fill out membership or subscription forms for the Alliance Against Fraud in Telemarketing, or use the online reporting form to report fraud or ask for advice.

How is personally identifiable information used?

  • People who ask for advice, online or offline, may be sent educational materials and information about the National Consumers League. Their names and contact information are not retained.
  • Information that individuals report about suspected telemarketing or Internet fraud is kept in a secure database and transmitted, with their permission, to the appropriate law enforcement agencies.
  • Information that individuals report about suspected telemarketing or Internet fraud is also transmitted to certain credit card issuers and associations, courier companies, and bank clearing house operators when the individuals have made payment through their services. In those cases, all personally identifying information about the complaining individuals is removed before transmission.
  • Personally identifying information about the individuals who report suspected fraud and the names of the sellers are not shared with the media or the general public, without that individual’s permission.
  • The Fraud Center does not share the names and contact information of law enforcement investigators who receive fraud reports except with other investigators or unless they give their affirmative consent to share that information for a specific purpose.
  • Individuals who report suspected fraud are sent educational materials and information about the National Consumers League.
  • When individuals who contact the Fraud Center make a donation or become members of NCL, they continue to receive information about NCL activities.
  • Payment information in connection with donations or memberships is shared with others only to the extent needed for processing.

Who do I contact if I have questions or concerns about this privacy policy?

If you have any questions or problems concerning NCL’s privacy practices, contact info@nclnet.org or (202) 835-3323.

  • Our Impact

    The work of the National Consumers League is making a difference in people’s lives across the country. Meet some of the consumers touched by our programs.

    Read about NCL’s impact

  • Preventing yet another victim

    Paige, 55, a Nashville wife and mother of two, answered an employment ad for secret shoppers. Before sending payment to the scammers, she reached out to NCL.

    Read about NCL’s impact

  • Building a stronger generation

    A grease fire flared up in Decklan’s kitchen. As his family scrambled and panicked, fearing that the whole house might erupt in flames, Decklan remained calm. He hurried over to the pantry, grabbed some baking soda, and dumped it on the fire quickly extinguishing the blaze.

    Read about NCL’s impact

  • Script Your Future saved my life

    Cincinnati resident Charles, 45, lost his computer business — and health insurance— during a time of economic downturn. A diabetic, Charles was now unable to afford his medication. He stopped taking it which made him seriously ill and put his life at risk.

    Read about NCL’s impact

  • For a safer workplace

    Jeremy is a fast-food worker who has been employed at a number of Chipotle restaurants in New York City. When he was just 20 years old, he took part in an NCL research project that revealed that management practices within the fast food chain were putting workers—and food safety for customers—at risk.

    Read about NCL’s impact

  • Our Impact

  • Preventing yet another victim

  • Building a stronger generation

  • Script Your Future saved my life

  • For a safer workplace

Our Programs

About NCL

  • About Us
  • Our Programs
  • Leadership
  • Trumpeter Awards
  • Legal Work
  • Careers

Our Work

  • Fraud Prevention
  • Health
  • Food & Nutrition
  • Consumer Education
  • Workers Rights
  • Consumer Protection

Where We Stand

  • Fraud Prevention
  • Health
  • Food & Nutrition
  • Consumer Education
  • Workers Rights
  • Consumer Protection
  • Blog
  • Media
  • Privacy Policy

National Consumers League

DONATE
© Copyright - National Consumers League
Scroll to top

Sign Up for Fraud Alerts

Podcast Subscribe Form

"*" indicates required fields

Name*

Join the Campaign

"*" indicates required fields

Name*
ZIP / Postal Code*

PBPA Commends HHS Funding to Support Maternal and Infant Health

The Preterm Birth Prevention Alliance (PBPA), a coalition of maternal and women’s health advocates dedicated to improving preterm birth outcomes in the United States and addressing its disproportionate impact on women of color, applauds the U.S. Department of Health and Human Services (HHS) for awarding nearly $350 million to states across the country to improve support for safe pregnancies and healthy babies.

“For far too long, U.S. maternal health care has lagged behind that of other developed countries, particularly for women of color,” noted Sally Greenberg, Executive Director of the National Consumers League. “This additional funding will enable local health departments and nonprofits to better address the health care needs of the most vulnerable mothers and their babies.”

The funding, awarded by HHS’ Health Resources and Services Administration (HRSA), will support home visiting services, increase access to doulas, address infant mortality and maternal illness, and improve data reporting on maternal mortality.

“Maternal health care in the U.S. has consistently failed women of color,” Greenberg continued.  “We applaud HHS for this additional funding that will help to improve the maternal health for all mothers and babies, especially women of color and those most at-risk.”

The funding announcement follows the release of a report by the U.S. Commission on Civil Rights which found that Native American women are more than two times more likely to die from pregnancy-related complications than white women in the U.S. This disparity was further exacerbated for Black women in the U.S., who are three to four times more likely to die from pregnancy-related complications than white women.

“In addition to expanding programs to support maternal health, we must increase representation from racially and ethnically diverse groups in research and clinical trials, particularly those studying treatment options to prevent maternal morbidity and mortality,” said Greenberg.  “The need for the additional HHS funding and the report from the Commission on Civil Rights clearly illustrate how critical representative research and real world evidence are to ensuring all mothers and their babies have the same opportunity for the best possible health outcomes.”

Diverse research for a diverse America: The value of equitable, real-world research

August 12, 2021/in Blog, Health, Prevention Blog Post

By Sally Greenberg, NCL Executive Director

While the COVID-19 pandemic has led to hardship for all Americans, it is clear that people of color have been disproportionately burdened. Across the health care continuum, addressing this disparity has become part of the broader conversation about the history of systemic racism and the underlying social determinants of health that negatively affect the mental, physical, and economic health of individuals and entire communities.

The pandemic has underscored persistent health disparities, and there is growing recognition that representation in research and clinical trials can have a profound impact on health outcomes. A lack of representation from racially and ethnically diverse groups in research and clinical trials have typically led to gaps in data, missing the opportunity to assess the full impact of various treatments and drugs across a range of populations. The collection and use of real-world research and data to inform the potential use, risks, and benefits of medical products and treatments can ultimately lead to better health outcomes, particularly for those who have been underrepresented in the past.

Existing efforts to improve inclusion

Efforts to expand diversity and representation in medical research are underway in Congress. Policymakers are encouraging the incorporation of Real World Evidence (RWE) in drug development through the recent Cures 2.0 draft legislation released by Reps. Diana Degette (D-CO-1) and Fred Upton (D-MI-6). While the status quo limits us from effectively reaching underserved populations, the proposed legislation would allow studies that include RWE for some drugs after they have been approved. At the heart of this issue is a growing appreciation that the same therapy can affect different populations in different ways, which is why Cures 2.0 supports collecting data that more accurately reflects the unique experiences and needs of patients across diverse populations.

Recognizing the potential for RWE in maternal health

The lack of representative research in the field of maternal health is undeniable, and its implications are staggering. The dismal state of maternal care in the United States reflects how our health care system has failed women of color, including by not adequately studying treatment options to prevent maternal morbidity and mortality. The need for RWE is clear when you consider the persistent disparities in health outcomes that plague minority communities.

Preterm birth and its disproportionate impact on women of color is a stark illustration of the need to make progress on representative research in maternal health. Preterm birth is the second-largest contributor to infant death in America today. Despite the tremendous physical, emotional, and financial toll that preterm birth continues to take on our country — disproportionately so on women and families of color — not enough therapeutic tools currently exist to prevent it.

Today, “17P,” the only FDA-approved treatment to help reduce the likelihood of spontaneous, recurrent preterm birth in the United States is at-risk of being withdrawn from the market in all its forms, including the branded product and five generic versions. Unfortunately there is conflicting evidence from two different clinical trials, one representative of a diverse U.S. population and another studied in a largely white population in Europe. It’s not a straightforward comparison. If 17P is withdrawn, the women most affected by preterm birth, predominantly women of color, would be left without an FDA-approved treatment option.

The FDA is considering the path forward, including additional data collection through leveraging RWE from past patient use. The success of the first (approval) trial for 17P in the impacted communities signals the importance of RWE. Continued access to 17P is, at its core, a matter of health equity. Black women must not yet again be left vulnerable to a system that historically has overlooked them.

PRETERM BIRTH PREVENTION ALLIANCE APPLAUDS FDA’S GRANTING OF HEARING FOR THE ONLY FDA-APPROVED THERAPIES TO REDUCE RECURRENT PRETERM BIRTH

WASHINGTON, DC, August 26, 2021 –

Preterm Birth Prevention Alliance a coalition of maternal and women’s health advocates dedicated to improving preterm birth outcomes in the United States and addressing its disproportionate impact on women of color, commends the U.S. Food and Drug Administration (FDA) for granting a public hearing to discuss 17P, the only FDA-approved class of branded and generic treatments to reduce preterm birth in indicated patients.

We appreciate the FDA’s willingness to hear directly from individuals facing prematurity and the providers who treat them about their experiences with 17P,” said National Consumer League’s Executive Director Sally Greenberg. “It is an important step towards better understanding variations in efficacy across diverse populations and ensuring all women have an equal chance at the best possible outcomes.”

Last week, the FDA agreed to grant Covis Pharma, the manufacturer of the branded 17P product Makena its request for a public hearing to discuss 17P. Hydroxyprogesterone caproate—or “17P”—has been approved since 2011 and is the only FDA-approved class of treatments to help prevent spontaneous, recurrent preterm birth in the United States. In 2020, the FDA proposed withdrawing 17P in all its forms, including the branded product and its five generic versions, based on conflicting efficacy data from two studies composed of vastly different populations, one predominantly inclusive of women in the U.S. most vulnerable to preterm birth and one not.

“Mothers and birthing people deserve access to the best possible treatments to prevent preterm birth. We cannot achieve birth equity if we study pregnant women as a monolith,” said Blythe Thomas, Initiative Director of 1,000 Days. “It is only by systematically researching the real-world, post-market impact of 17P on individuals from a variety of racial and ethnic backgrounds, while maintaining access for all affected, that we can reduce disparities in maternal and infant health.”

While the hearing date has not yet been set, the Alliance looks forward to sharing the perspectives of affected individuals and their physicians with the agency once the hearing is scheduled and will continue to advocate for at-risk moms and babies of all races and ethnicities.

###

ABOUT THE PRETERM BIRTH PREVENTION ALLIANCE

The Preterm Birth Prevention Alliance (PBPA) is a coalition of maternal and women’s health advocates who share a common concern about the state of preterm birth in the United States and the proposed market withdrawal of 17P, the only FDA-approved class of treatments to help prevent spontaneous, recurrent preterm birth. Formed in 2021 by the National Consumers League, the 15 partners in the PBPA seek to improve preterm birth outcomes in the United States by maintaining access to safe, FDA-approved treatment options and advocating for more diverse medical research that adequately represents the experiences of women and newborns of color. Women of color need a seat at the table. To learn more, visit www.pretermbirthalliance.org

LEADING PATIENT ADVOCATES LAUNCH PRETERM BIRTH PREVENTION ALLIANCE TO PROTECT CRITICAL ACCESS TO THE SOLE FDA-APPROVED CLASS OF THERAPIES TO REDUCE RECURRENT PRETERM BIRTH

WASHINGTON, DC, April 20, 2021 – Today, the National Consumers League (NCL), along with a coalition of patient advocacy organizations dedicated to advancing the health of mothers and infants, announced the launch of the >Preterm Birth Prevention Alliance.

Members of the Alliance are joining forces in an effort to preserve patient access to the only Food & Drug Administration-approved class of treatments for pregnant women who have previously had an unexpected, or spontaneous, preterm birth. Together, Alliance members seek to ensure that the Food & Drug Administration (FDA) hears concerns from the full range of stakeholders about the potential risks and impact of withdrawal for at-risk pregnant women and their providers.

For the fifth year in a row, the U.S. preterm birth rate has increased (to 10.2 percent of births), and preterm birth and its complications were the second largest contributor to infant death across the country. Preterm birth also represents a significant racial health disparity, with Black women in America experiencing premature delivery at a rate 50 percent higher than other racial groups throughout the country.

However, in 2020, the FDA >proposed withdrawing hydroxyprogesterone caproate, commonly called “17P” or “17-OHPC”, the only FDA-approved class of branded and generic treatments to help prevent the risk of preterm birth in women with a history of spontaneous preterm birth. The FDA is currently determining whether to hold a hearing on the status of 17P, based on conflicting efficacy data from two studies composed of vastly different patient populations, one inclusive of women in the U.S. most vulnerable to preterm birth and one not.

“We’re fighting for a more inclusive healthcare system that gives everyone an equal chance to have the best outcomes possible,” said Sally Greenberg, executive director of the National Consumers League. “We don’t believe that removing 17P from the market without gaining a better understanding of who could benefit the most from its use is in the best interests of patients, nor their healthcare providers, particularly as there are no other approved treatment options available.”

To date, 14 organizations have joined NCL to advocate for the health interests of at-risk pregnant women and infants, including: 1,000 Days; 2020 Mom; American Association of Birth Centers; Black Mamas Matter Alliance; Black Women’s Health Imperative; Expecting Health; Healthy Mothers, Healthy Babies Montana; HealthyWomen; Miracle Babies; National Birth Equity Collaborative; National Black Midwives Alliance; National Partnership for Women & Families; Sidelines High-Risk National Support Network; and SisterReach.

“As a trained obstetrician and gynecologist, I know firsthand the impact of preterm birth on Black women and birthing people. I also know that racism – not race – is the driving factor leading the disproportionate impact of preterm birth on Black women and birthing people thereby exacerbating systemic inequities in maternal and infant health. To achieve birth equity, which is the assurance of the conditions of optimal births for all people with a willingness to address racial and social inequities in a sustained effort, we must work to protect and uphold a standard of care for spontaneous, recurrent preterm births and ensure it remains accessible and affordable for all who stand in need,” added Dr. Joia Crear Perry, founder and president of the National Birth Equity Collaborative.

The Preterm Birth Prevention Alliance is calling for the FDA to grant a public hearing to fully consider all of the data, additional research methods, and stakeholder perspectives before deciding whether to withdraw approval of this critical class of therapies. The health of America’s moms and babies warrants the utmost care and consideration.

###

ABOUT THE PRETERM BIRTH PREVENTION ALLIANCE

The Preterm Birth Prevention Alliance is a coalition of maternal and women’s health advocates who share a common concern about the state of preterm birth in the United States and the proposed market withdrawal of 17P, the only FDA-approved class of treatments to help prevent spontaneous, recurrent preterm birth. Formed in 2021 by the National Consumers League, we seek to improve preterm birth outcomes in the United States by maintaining access to safe, FDA-approved treatment options and advocating for more diverse medical research that adequately represents the experiences of women and newborns of color. Women of color need a seat at the table. To learn more, visit www.pretermbirthalliance.org.

Initial support for the Preterm Birth Prevention Alliance is provided by Covis Pharma.

MEDIA CONTACT:

Carol McKay, carolm@nclnet.org

<embed src=”https://art19.com/shows/ce489618-5918-423a-9b5f-35ce4c28ca09/episodes/2f8fa6fc-6aad-4f1f-bf13-3bdb0aa41732/embed?theme=light-custom&primary_color=%231850a3″ width=”100%” height=”300″></embed>

<iframe src=”https://art19.com/shows/we-can-do-this/episodes/c7b22520-c0aa-4718-9b59-4ee67e494547/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>

<iframe src=”https://art19.com/shows/we-can-do-this/episodes/ab80228e-48d9-4a45-a894-a1bfc4e41c64/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>

<iframe src=”https://art19.com/shows/we-can-do-this/episodes/ea08cbc0-f9f2-4082-9222-4e33f68b6826/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>

<iframe src=”https://art19.com/shows/we-can-do-this/episodes/5039453f-6008-413a-9f6b-c9be649fd26e/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>

<iframe src=”https://art19.com/shows/we-can-do-this/episodes/fafb46f8-6d90-4cd8-91be-616366d1b8ca/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>

<iframe src=”https://art19.com/shows/we-can-do-this/episodes/25f0485d-bbce-46c8-bb90-139dcf1a2e7b/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>

<iframe src=”https://art19.com/shows/we-can-do-this/episodes/ffbcae35-84c5-4c8b-9686-6e2c79679dd0/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>

<iframe src=”https://art19.com/shows/we-can-do-this/episodes/520bdd73-d142-4508-9706-d81b5c042dff/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>

<iframe src=”https://art19.com/shows/we-can-do-this/episodes/12354e8b-bf15-4eba-b34f-20e435df3bb7/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>

<iframe src=”https://art19.com/shows/we-can-do-this/episodes/e2091efc-d66d-49f4-aa8e-8e6249858310/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>